Shares of Fresenius Medical Care AG (ETR:FME – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as €43.18 ($45.45) and last traded at €43.09 ($45.36), with a volume of 430316 shares traded. The stock had previously closed at €41.60 ($43.79).
Fresenius Medical Care Stock Up 3.6 %
The stock has a market cap of $12.64 billion, a P/E ratio of 23.81, a PEG ratio of 0.42 and a beta of 0.86. The firm’s 50-day moving average is €38.79 and its two-hundred day moving average is €37.44. The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- Best Stocks Under $10.00
- How to Master Trading Discipline: Overcome Emotional Challenges
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- What is a Stock Market Index and How Do You Use Them?
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
